文献速递血栓与止血

血小板表面磷脂酰丝氨酸降低预测重型血友病A患者出血增加

Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency.
PubMed 文献 · J Thromb Haemost · 2021-03-07

本研究在34例接受预防性FVIII治疗的重型FVIII缺乏患者中,评估血小板功能标志物与既往及未来出血的关联。结果显示,无论有无ADP/凝血酶受体激活肽刺激,血小板表面磷脂酰丝氨酸表达降低(annexin V结合法)均与既往和后续任何部位出血、尤其关节出血显著相关,而其他血小板活性标志物无显著差异。提示血小板表面磷脂酰丝氨酸表达降低可预测重型FVIII缺乏患者预防治疗下的出血增加。

要点

  • 血小板表面磷脂酰丝氨酸降低与既往及后续出血显著相关。
  • 该关联见于任何部位出血,尤其关节出血。
  • 其他血小板活性标志物与出血无显著差异。

核心结论

  • 血小板表面磷脂酰丝氨酸表达降低(annexin V结合法)预测接受预防治疗的重型FVIII缺乏患者出血增加。

研究设计与样本

  • 在34例重型FVIII缺乏患者中评估血小板功能标志物与既往和/或未来出血的关联。

主要发现

  • 血小板表面磷脂酰丝氨酸表达降低在有和无ADP/凝血酶受体激活肽时均与既往和后续任何部位出血显著相关。
  • 血小板表面磷脂酰丝氨酸表达降低与关节出血显著相关。
  • 其他血小板活性标志物在有和无出血患者间无显著差异。

临床怎么用

  • 可通过annexin V结合法检测血小板表面磷脂酰丝氨酸表达,辅助识别接受预防治疗的重型FVIII缺乏患者中的高出血风险者。

局限性

  • 样本量仅34例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bleeding phenotypes among individuals with severe factor VIII (FVIII) deficiency are variable, even with routine prophylactic FVIII administration. Activated platelets, in addition to their role in primary hemostasis, play a major role in coagulation by providing a phospholipid surface to which coagulation factors bind. OBJECTIVES: The aim of this study was to determine whether platelet function is associated with past and/or future bleeding in patients with severe FVIII deficiency on prophylaxis. PATIENTS/METHODS: Platelet function quantified by platelet surface expression of phosphatidylserine, platelet surface glycoprotein (GP) VI, platelet surface activated GPIIb-IIIa, platelet surface P-selectin, the percentage of coated platelets, and the percentage of platelet-derived microparticles in the presence or absence of in vitro activation by various agonists was assessed in 34 patients. RESULTS: Decreased platelet surface phosphatidylserine expression (identified by annexin V binding), both in the presence and absence of ADP/thrombin receptor activating peptide, demonstrated a significant association with both prior and subsequent bleeding in any location and specifically with hemarthrosis. No significant difference between patients with and without bleeding was observed in any of the other platelet activity markers. CONCLUSIONS: Decreased platelet surface phosphatidylserine expression measured by annexin V binding predicts increased bleeding in severe FVIII deficient patients on prophylaxis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Croteau SE, Frelinger AL, Gerrits AJ, et al. Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency. J Thromb Haemost. 2021. PMID: 33370471. doi:10.1111/jth.15223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。